SCHEMBL4769319

SCHEMBL4769319

CCCCn1c(=O)c([N+](=O)[O-])c(/C=C/c2cnn(Cc3ccccc3C(F)(F)F)c2)n(CCOC)c1=O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 10/20 0.44
ADORA1 P30542 9/20 0.44
ADORA2A P29274 6/20 0.44
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
ADORA3 P0DMS8 4/20 0.34
SCD5 Q86SK9 1/20 0.33
MAPT P10636 2/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPBWR1 P48145 1/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPK1 P28482 2/20 0.33
PKM P14618 1/20 0.32
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766139 0.95 ADORA2B (0.49) ADORA2BADORA1ADORA2ANCOA1NCOA3
SCHEMBL4763384 0.95 ADORA2B (0.44) ADORA2BADORA1ADORA2ANCOA1NCOA3
SCHEMBL4770747 0.95 ADORA2B (0.48) ADORA2BADORA1ADORA2ANCOA1NCOA3
SCHEMBL4770754 0.95 ADORA2B (0.48) ADORA2BADORA1ADORA2ANCOA1NCOA3
SCHEMBL4766145 0.92 ADORA2B (0.41) ADORA2BADORA1ADORA2ANCOA1NCOA3
SCHEMBL4763211 0.91 ADORA2B (0.42) ADORA2BADORA1ADORA2ANCOA1NCOA3
SCHEMBL4770837 0.90 ADORA2B (0.43) ADORA2BADORA1ADORA2ANCOA1NCOA3
SCHEMBL4770831 0.90 ADORA2B (0.43) ADORA2BADORA1ADORA2ANCOA1NCOA3
SCHEMBL4769323 0.89 ADORA2B (0.42) ADORA2BADORA1ADORA2ANCOA1NCOA3
SCHEMBL4769690 0.87 ADORA2B (0.52) ADORA2BADORA1ADORA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed